PDRN for Under-Eye Wrinkles: How It Works, Evidence & Treatment Options

How PDRN Targets Under-Eye Wrinkles

PDRN addresses under-eye wrinkles through targeted stimulation of the periorbital skin's depleted fibroblast population. By binding adenosine A2A receptors, PDRN activates these fibroblasts to increase production of type I and type III collagen, elastin, and glycosaminoglycans — rebuilding the structural matrix that gives the under-eye area its firmness and resilience. The anti-inflammatory component of PDRN's A2A signaling is particularly valuable around the eyes, where chronic low-grade inflammation from UV exposure, rubbing, and allergic responses accelerates collagen breakdown and contributes to the crepey texture characteristic of periorbital aging. PDRN also promotes angiogenesis in the periorbital dermis, improving microcirculation to the thin tissue — this enhanced blood supply supports both ongoing tissue health and the delivery of nutrients needed for collagen synthesis. Additionally, the nucleotide fragments from PDRN metabolism enter the salvage pathway, providing building blocks for DNA repair in UV-damaged periorbital cells and supporting the rapid cell turnover that healthy under-eye skin requires.

Conventional treatments for under-eye wrinkles include topical retinoids (limited by the area's extreme sensitivity), hyaluronic acid fillers (which address volume loss but not skin quality), botulinum toxin for dynamic crow's feet (which relaxes muscles but does not rebuild collagen), and laser resurfacing (which carries significant risk of hyperpigmentation and prolonged healing in this delicate area).

PDRN has emerged as a uniquely suitable treatment for periorbital rejuvenation because its mechanism — adenosine A2A receptor activation on fibroblasts — is gentle enough for the thin periorbital skin while still producing meaningful collagen stimulation and tissue repair. Unlike retinoids, PDRN causes no irritation, peeling, or photosensitivity. Unlike fillers, PDRN improves actual skin quality rather than just adding volume. And unlike laser procedures, PDRN requires no downtime and carries no risk of thermal damage to the delicate periorbital tissue.

Clinical experience from Korean aesthetic clinics has demonstrated that PDRN skin booster injections in the periorbital area produce measurable improvements in skin hydration, elasticity, fine line depth, and overall skin quality — with the thin periorbital skin often showing results faster than thicker facial areas because the fibroblasts are closer to the surface and more accessible to the active ingredient.